ProShare Advisors
VIVO

ProShare Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

ProShare Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,808
Closed -$226K – 1949
2022
Q4 		$226K Buy
+6,808
New +$219K ﹤0.01% 1409
2022
Q2 		– Sell
-9,513
Closed -$246K – 2242
2022
Q1 		$246K Sell
9,513
-1,163
-11% -$27.7K ﹤0.01% 1764
2021
Q4 		$217K Buy
+10,676
New +$205K ﹤0.01% 1982
2021
Q3 		– Sell
-12,239
Closed -$271K – 2347
2021
Q2 		$271K Sell
12,239
-391
-3% -$8.29K ﹤0.01% 1960
2021
Q1 		$332K Buy
12,630
+2,426
+24% +$57.7K ﹤0.01% 1742
2020
Q4 		$191K Buy
+10,204
New +$191K ﹤0.01% 1860
2014
Q4 		– Sell
-17,577
Closed -$311K – 2169
2014
Q3 		$311K Sell
17,577
-4,337
-20% -$85.2K ﹤0.01% 1692
2014
Q2 		$452K Sell
21,914
-20,960
-49% -$431K 0.01% 1647
2014
Q1 		$934K Buy
+42,874
New +$983K 0.01% 1365
2013
Q4 		– Sell
-27,092
Closed -$641K – 1981
2013
Q3 		$641K Sell
27,092
-1,394
-5% -$32.6K 0.02% 1244
2013
Q2 		$612K Buy
+28,486
New +$614K 0.01% 1172

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ProShare Advisors's VIVO Position: Q1 2023 in Review

ProShare Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,808 shares — an estimated $226K sold.

ProShare Advisors first reported a position in VIVO in Q2 2013 and held it in 11 quarters. The position peaked at $934K in Q1 2014. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • ProShare Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • ProShare Advisors sold 6,808 Meridian Bioscience Inc shares in Q1 2023, an estimated $226K.
  • ProShare Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 11 quarters.
  • ProShare Advisors's Meridian Bioscience Inc position peaked at $934K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on ProShare Advisors's 13F filing for Q1 2023, filed 12 May 2023.